Enhanced antitumor activity of trastuzumab emtansine (T-DM1) in combination with pertuzumab in a HER2-positive gastric cancer modelYoriko Yamashita‐Kashima, Kaori Fujimoto-Ouchi|Oncology Reports|2013Cited by 46
Biomarkers for antitumor activity of bevacizumab in gastric cancer modelsYoriko Yamashita‐Kashima, Kazushige Mori|BMC Cancer|2012Cited by 32
Mode of action of pertuzumab in combination with trastuzumab plus docetaxel therapy in a HER2-positive breast cancer xenograft modelYoriko Yamashita‐Kashima, Naoki Harada|Oncology Letters|2017Cited by 25